Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

被引：7
|
作者：
Sedhom, Ramy [1 ]
Antonarakis, Emmanuel S. [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2019年 / 8卷
基金：
美国国家卫生研究院;
关键词：
BONE METASTASIS; SURVIVAL; ENZALUTAMIDE; ACETATE;
D O I：
10.21037/tau.2019.05.02
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S341 / S345
页数：5
相关论文
共 50 条
  • [41] High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Christensen, Bryce Raymon
    Barata, Pedro C.
    Ledet, Elisa M.
    Layton, Jodi L.
    Lewis, Brian E.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 476 - 479
  • [42] Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Buzzacchino, Federica
    Pozzi, Chiara
    Ferrara, Carla
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Civitelli, Liana
    De Vincentis, Giuseppe
    Tomao, Silverio
    Bianco, Vincenzo
    ONCOLOGY LETTERS, 2019, 17 (02) : 1467 - 1476
  • [43] Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223
    Poon, Darren M. C.
    Wong, Kenneth C. W.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E397 - E401
  • [44] DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223
    Ramos, Jorge D.
    Mostaghel, Elahe A.
    Pritchard, Colin C.
    Yu, Evan Y.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 106 - 110
  • [45] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [46] Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice
    Morgan, Scott C.
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2019, 50 (04) : S26 - S30
  • [47] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [48] Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer
    Picciotto, Maria
    Franchina, Tindara
    Russo, Alessandro
    Ricciardi, Giuseppina Rosaria Rita
    Provazza, Giusy
    Sava, Serena
    Baldari, Sergio
    Caffo, Orazio
    Adamo, Vincenzo
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 899 - 908
  • [49] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [50] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
12345